Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

PURPOSE: Large, generalizable real-world data can enhance traditional clinical trial results. The current study evaluates reliability, clinical relevance, and large-scale feasibility for a previously documented method with which to characterize cancer progression outcomes in advanced non–small-cell...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JCO Clin Cancer Inform
Hlavní autoři: Griffith, Sandra D., Miksad, Rebecca A., Calkins, Geoff, You, Paul, Lipitz, Nicole G., Bourla, Ariel B., Williams, Erin, George, Daniel J., Schrag, Deborah, Khozin, Sean, Capra, William B., Taylor, Michael D., Abernethy, Amy P.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2019
Témata:
Original Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873982/
https://ncbi.nlm.nih.gov/pubmed/31403818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.19.00013
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky